PAVmed (NASDAQ:PAVM) is set to give its latest quarterly earnings report on Wednesday, 2023-03-15. Here's what investors need to know before the announcement.
Analysts estimate that PAVmed will report an earnings per share (EPS) of $-0.25.
PAVmed bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Past Earnings Performance
Last quarter the company beat EPS by $0.11, which was followed by a 12.31% drop in the share price the next day.
Here's a look at PAVmed's past performance and the resulting price change:
| Quarter | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.26 | -0.23 | -0.20 | -0.15 |
| EPS Actual | -0.15 | -0.17 | -0.14 | -0.15 |
| Price Change % | -12.31% | -30.81% | -4.63% | -10.56% |
Stock Performance
Shares of PAVmed were trading at $0.4152 as of March 13. Over the last 52-week period, shares are down 63.49%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.
To track all earnings releases for PAVmed visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
PAVmed (NASDAQ:PAVM) is set to give its latest quarterly earnings report on Wednesday, 2023-03-15. Here's what investors need to know before the announcement.
帕夫邁德 (新聞資料代碼:PAVVM) 將於 2020 年 3 月 15 日（星期三）公布其最新的季度盈利報告。以下是投資者在公佈之前需要了解的內容。
Analysts estimate that PAVmed will report an earnings per share (EPS) of $-0.25.
分析師估計，PavMed 將報告 每股盈利 （每股盈利）為 0.25 美元。
PAVmed bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
PavMed 多頭將希望聽到該公司宣布，他們不僅擊敗了這一估計，而且還為下一季度提供積極的指導或預測的增長。
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
新投資者應注意，有時候影響股票價格有時並不是盈利擊敗或錯過，而是影響股票價格的指引（或預測）。
Past Earnings Performance
過往收益表現
Last quarter the company beat EPS by $0.11, which was followed by a 12.31% drop in the share price the next day.
上個季度，該公司以 0.11 美元擊敗每股收益，其次是第二天股價下跌 12.31%。
Here's a look at PAVmed's past performance and the resulting price change:
以下是 PavMed 過去的表現和由此產生的價格變化：
| Quarter | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.26 | -0.23 | -0.20 | -0.15 |
| EPS Actual | -0.15 | -0.17 | -0.14 | -0.15 |
| Price Change % | -12.31% | -30.81% | -4.63% | -10.56% |
| 季度 | 2022 年第三季 | 第二季 | 2022 年第一季 | 第四季 |
|---|---|---|---|---|
| 每股盈餘估 | -0.26 | -0.23 | -0.20 | -0.15 |
| 實際盈餘 | -0.15 | -0.17 | -0.14 | -0.15 |
| 價格變動% | -12.31% | -30.81% | -4.63% | -10.56% |
Stock Performance
股票表現
Shares of PAVmed were trading at $0.4152 as of March 13. Over the last 52-week period, shares are down 63.49%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.
截至 3 月 13 日，PavMed 的股票交易價格為 0.4152 美元。在過去 52 周期間，股票下跌了 63.49%。鑑於這些回報通常是負值的，因此長期股東可能會不安進入此盈利發布。
To track all earnings releases for PAVmed visit their earnings calendar on our site.
要跟踪 PavMed 的所有收益發布，請訪問我們網站上的收益日曆。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由 Beninga 的自動化內容引擎生成，並由編輯審查。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧